Items where authors include "Marshall, R."

Article

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Yuille, A. orcid.org/0000-0003-2327-2263, Davies, J., Green, M. et al. (33 more authors) (2024) Moving from features to functions: bridging disciplinary understandings of urban environments to support healthy people and ecosystems. Health & Place, 90. 103368. ISSN 1353-8292

Rotundo, J.L., Marshall, R., McCormick, R. et al. (22 more authors) (2024) European soybean to benefit people and the environment. Scientific Reports, 14. 7612. ISSN 2045-2322

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736

Kousathanas, A. orcid.org/0000-0001-6265-6521, Pairo-Castineira, E. orcid.org/0000-0002-2423-3090, Rawlik, K. orcid.org/0000-0002-0010-370X et al. (2377 more authors) (2022) Whole-genome sequencing reveals host factors underlying critical COVID-19. Nature, 607. pp. 97-103. ISSN 0028-0836

Proceedings Paper

Ryan, A., Bates, E., Danson, S. orcid.org/0000-0002-3593-2890 et al. (7 more authors) (2020) Outcomes of patients in South Yorkshire with advanced non-small-cell lung cancer treated with second-line atezolizumab following induction with chemotherapy. In: Lung Cancer. 18th Annual British Thoracic Oncology Group Conference 2020, 29-31 Jan 2020, Dublin, Ireland. .

Marshall, R., Kakoudaki, M., Danson, S.J. orcid.org/0000-0002-3593-2890 et al. (7 more authors) (2017) 66: Outcomes of patients in the North Trent region with advanced non-small-cell lung cancer treated with maintenance pemetrexed following induction with platinum non-pemetrexed doublet chemotherapy. In: Lung Cancer. 15th Annual British Thoracic Oncology Group Conference 2017, 25-27 Jan 2017, Dublin, Ireland. Elsevier , S31-S31.

Kakoudaki, M., Marshall, R., Danson, S.J. orcid.org/0000-0002-3593-2890 et al. (7 more authors) (2017) 67: Outcomes of patients in South Yorkshire who received maintenance pemetrexed treatment for non-squamous, non-small-cell cancer after induction chemotherapy with pemetrexed and cisplatin. In: Lung Cancer. 15th Annual British Thoracic Oncology Group Conference, 25-27 Jan 2017, Dublin, Ireland. Elsevier , S31-S31.